TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

Q: What does CUSIP 881624209 represent in this 13F holders report?

CUSIP 881624209 is the security identifier for TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in Q2 2019?

434 institutional investors reported TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share for Q2 2019. Use the holders table for investor-level position and value details.

CUSIP: 881624209

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Ordinary Shares, par value NIS 0.01 per share
Shares outstanding: 1,148,777,709
Total 13F shares: 640,277,265
Share change: -20,324,716
Total reported value: $5,906,782,225
Put/Call ratio: 192%
Price per share: $9.23
Number of holders: 434
Value change: -$439,059,091
Number of buys: 196
Number of sells: 234

Quarterly Holders Quick Answers

What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 881624209:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	11%	128,191,392	$2,010,041,000	—	31 Mar 2019	13F
FRANKLIN RESOURCES INC	13F	Company	5.6%	64,623,884	$1,013,298,000	—	31 Mar 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.1%	58,496,544	$917,225,000	—	31 Mar 2019	13F
Capital World Investors	13F	Company	4.1%	46,628,665	$731,137,000	—	31 Mar 2019	13F
BERKSHIRE HATHAWAY INC	13F	Company	3.8%	43,249,295	$678,149,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	2.9%	33,782,597	$529,710,000	—	31 Mar 2019	13F
ABRAMS CAPITAL MANAGEMENT, L.P.	13F	Company	1.6%	18,046,356	$282,967,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	1.5%	17,064,587	$267,574,000	—	31 Mar 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.1%	12,905,046	$202,351,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	0.92%	10,622,421	$166,560,000	—	31 Mar 2019	13F
Polaris Capital Management, LLC	13F	Company	0.89%	10,211,580	$160,118,000	—	31 Mar 2019	13F
NORGES BANK	13F	Company	0.8%	9,210,016	$144,412,000	—	31 Mar 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.69%	7,960,189	$124,816,000	—	31 Mar 2019	13F
Brahman Capital Corp.	13F	Company	0.61%	7,064,540	$110,772,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.59%	6,782,021	$106,342,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.59%	6,763,360	$106,050,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.57%	6,586,071	$103,270,000	—	31 Mar 2019	13F
Harel Insurance Investments & Financial Services Ltd.	13F	Company	0.46%	5,321,613	$83,443,000	—	31 Mar 2019	13F
HIGHFIELDS CAPITAL MANAGEMENT LP	13F	Company	0.46%	5,295,102	$83,027,000	—	31 Mar 2019	13F
Delek Group, Ltd.	13F	Company	0.45%	5,137,383	$80,157,000	—	31 Mar 2019	13F
MILLER VALUE PARTNERS, LLC	13F	Company	0.4%	4,542,532	$71,227,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.38%	4,308,339	$67,555,000	—	31 Mar 2019	13F
BECK MACK & OLIVER LLC	13F	Company	0.36%	4,165,839	$65,320,000	—	31 Mar 2019	13F
CITIGROUP INC	13F	Company	0.36%	4,111,455	$64,467,000	—	31 Mar 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.36%	4,079,000	$63,959,000	—	31 Mar 2019	13F
Swiss National Bank	13F	Company	0.31%	3,571,299	$55,998,000	—	31 Mar 2019	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.31%	3,546,323	$55,606,000	—	31 Mar 2019	13F
Camber Capital Management LP	13F	Company	0.3%	3,500,000	$54,880,000	—	31 Mar 2019	13F
Migdal Insurance & Financial Holdings Ltd.	13F	Company	0.3%	3,427,995	$53,749,000	—	31 Mar 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.3%	3,413,301	$53,520,000	—	31 Mar 2019	13F
THORNBURG INVESTMENT MANAGEMENT INC	13F	Company	0.29%	3,335,555	$52,302,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.28%	3,252,265	$50,881,000	—	31 Mar 2019	13F
Redmile Group, LLC	13F	Company	0.27%	3,147,000	$49,345,000	—	31 Mar 2019	13F
CREDIT SUISSE AG/	13F	Company	0.27%	3,143,260	$49,286,000	—	31 Mar 2019	13F
Clal Insurance Enterprises Holdings Ltd	13F	Company	0.27%	3,087,266	$48,408,000	—	31 Mar 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.26%	3,041,827	$47,696,000	—	31 Mar 2019	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.26%	2,983,088	$46,775,000	—	31 Mar 2019	13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC	13F	Company	0.26%	2,942,539	$46,139,000	—	31 Mar 2019	13F
Assured Investment Management LLC	13F	Company	0.24%	2,710,023	$42,493,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.23%	2,626,163	$41,178,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	2,579,110	$40,440,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.21%	2,387,884	$37,444,000	—	31 Mar 2019	13F
COMMERZBANK AKTIENGESELLSCHAFT /FI	13F	Company	0.19%	2,207,984	$34,621,000	—	31 Mar 2019	13F
AGF INVESTMENTS INC.	13F	Company	0.18%	2,055,042	$32,223,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.18%	2,032,411	$31,868,000	—	31 Mar 2019	13F
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management)	13F	Company	0.18%	2,018,926	$31,657,000	—	31 Mar 2019	13F
MENORA MIVTACHIM HOLDINGS LTD.	13F	Company	0.17%	1,963,896	$30,794,000	—	31 Mar 2019	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.17%	1,922,610	$30,147,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	0.16%	1,894,431	$29,705,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.16%	1,864,589	$29,238,000	—	31 Mar 2019	13F

Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2019

As of 30 Jun 2019, TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by 434 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 640,277,265 shares. The largest 10 holders included Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, Berkshire Hathaway Inc, Capital World Investors, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 434 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

494

Q2 2019 holders

434

Holder diff

-60

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.